Research map: Medical cannabis improved self-reported spasticity rating in patients with chronic spinal cord injury: a placebo-controlled, double-blind, crossover pilot clinical trial

Back to the article

Papers in this map

  1. Cardiovascular Disease in Spinal Cord Injury · JONATHAN N. MYERS · 2007 · 591 citations · Cited by this paper
  2. Narcolepsy with co-occurring epilepsy: diagnostic pitfalls and management strategy · 2026 · Related
  3. Spasticity after spinal cord injury · Melanie M. Adams · 2005 · 523 citations · Cited by this paper
  4. Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice · 2026 · Related
  5. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up · John Zajicek · 2005 · 337 citations · Cited by this paper
  6. Bilateral transcutaneous auricular nerve stimulation promotes motor function recovery after stroke: A randomized controlled trial · 2026 · Related
  7. Considerations for crossover design in clinical study · Chi‐Yeon Lim · 2021 · 241 citations · Cited by this paper
  8. Novel homozygous SYNE1 missense variant in late onset autosomal recessive cerebellar ataxia 1: a case report · 2026 · Related
  9. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons · Seyed Aria Nejadghaderi · 2024 · 235 citations · Cited by this paper
  10. Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysis · 2026 · Related
  11. THC and CBD: Similarities and differences between siblings · Nephi Stella · 2023 · 144 citations · Cited by this paper
  12. Heart rate and clinical outcome after endovascular treatment in patients with anterior versus posterior circulation large vessel occlusion · 2026 · Related
  13. Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits · Eva Hoch · 2024 · 133 citations · Cited by this paper
  14. The evolving treatment landscape of restless legs syndrome · 2026 · Related
  15. Outcome measures of spasticity · Garth R. Johnson · 2002 · 119 citations · Cited by this paper
  16. A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis · 2026 · Related
  17. White coat syndrome and its variations: differences and clinical impact · Mariana Rodrigues Pioli · 2018 · 117 citations · Cited by this paper
  18. Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case series · 2026 · Related
  19. Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain · Frank W. Petzke · 2021 · 94 citations · Cited by this paper
  20. A corona-like distribution and patchy pattern of cerebellar infarcts identify patients with giant cell arteritis · 2026 · Related
  21. Ratio of maximum H reflex to maximum M response as a measure of spasticity. · W.B. Matthews · 1966 · 82 citations · Cited by this paper
  22. The treatment of spasticity with Δ9-tetrahydrocannabinol in persons with spinal cord injury · U Hagenbach · 2006 · 69 citations · Cited by this paper
  23. The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients · G. B. ørsnes · 2000 · 66 citations · Cited by this paper
  24. A Randomized, Double-Blinded, Crossover Pilot Study Assessing the Effect of Nabilone on Spasticity in Persons With Spinal Cord Injury · Sepideh Pooyania · 2010 · 64 citations · Cited by this paper
  25. Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry · Michael A. Ueberall · 2019 · 63 citations · Cited by this paper
  26. Modified Ashworth scale and spasm frequency score in spinal cord injury: reliability and correlation · Carsten Bach Baunsgaard · 2016 · 48 citations · Cited by this paper
  27. Parametric and Nonparametric Tests in Spine Research: Why Do They Matter? · Sarah Hopkins · 2018 · 40 citations · Cited by this paper
  28. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination · Victor Longoria · 2022 · 33 citations · Cited by this paper
  29. Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration? · Andrea Valeri · 2021 · 27 citations · Cited by this paper
  30. Cardiac autonomic status is associated with spasticity in post-stroke patients · Chi-Yao Hung · 2014 · 10 citations · Cited by this paper
  31. A Pilot Study of the Government Pharmaceutical Organization (GPO) Cannabis Extract for Multiple Sclerosis (MS) Spasticity Treatment in Thailand · 2021 · 6 citations · Cited by this paper
  32. Neurobiology of Cannabinoids and Medical Cannabis in Therapeutic Intervention for Multiple Sclerosis · Mohammad Uzair · 2023 · 1 citation · Cited by this paper
  33. Investigating the effectiveness and adverse events of medicinal cannabis for patients with muscle spasticity or spasms · Xenia L. Nastatos · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)